Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
February 14 2025 - 4:47PM
Edgar (US Regulatory)
The following table sets forth all transactions in the Common Shares effected by the Reporting Persons since the filing of Amendment No. 5 on January 7, 2025.
All such transactions were effected in the open market through a broker.
Reporting Person
|
Title of Security
|
Date of Transaction
|
Nature of Transaction
|
Quantity
|
Price
|
GEM II
|
Common Shares
|
01/08/2025
|
Sell
|
14,994
|
|
$21.5104(1)
|
GEM II
|
Common Shares
|
01/10/2025
|
Sell
|
7,697
|
|
$21.5043(2)
|
GEM II
|
Common Shares
|
01/14/2025
|
Sell
|
11,913
|
|
$21.5072(3)
|
GEM II
|
Common Shares
|
01/15/2025
|
Sell
|
35,232
|
|
$21.5825(4)
|
GEM II
|
Common Shares
|
02/10/2025
|
Sell
|
26,000
|
|
$24.6621(5)
|
GEM II
|
Common Shares
|
02/12/2025
|
Sell
|
60,544
|
|
$26.2725(6)
|
(1) This transaction was executed in multiple trades at prices ranging from $21.50 to $21.5716, inclusive. The price reported above reflects the weighted average sale
price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth
herein.
(2) This transaction was executed in multiple trades at prices ranging from $21.50 to $21.51, inclusive. The price reported above reflects the weighted
average sale price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the
range set forth herein.
(3) This transaction was executed in multiple trades at prices ranging from $21.5 to $21.5231, inclusive. The price reported above reflects the weighted
average sale price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the
range set forth herein.
(4) This transaction was executed in multiple trades at prices ranging from $21.50 to $21.80, inclusive. The price reported above reflects the weighted
average sale price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the
range set forth herein.
(5) This transaction was executed in multiple trades at prices ranging from $24.615 to $24.8998, inclusive. The price reported above reflects the weighted
average sale price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the
range set forth herein.
(6) This transaction was executed in multiple trades at prices ranging from $26.131 to $26.471, inclusive. The price reported above reflects the weighted
average sale price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of Common Shares sold at each separate price within the range
set forth herein.
IBEX (NASDAQ:IBEX)
Historical Stock Chart
From Jan 2025 to Feb 2025
IBEX (NASDAQ:IBEX)
Historical Stock Chart
From Feb 2024 to Feb 2025